文献速递神经与头颈病理细胞病理与分子病理

腮腺切开活检与粗针活检的诊断性能及类MSRSGC风险分层模型评估

Performance Characteristics of Incisional and Core Needle Biopsies for Diagnosis in Parotid Gland: Single-Institutional Experience and Assessment of the Value of a Milan System for Reporting Salivary Gland Cytopathology-Like Risk Stratification Model.
PubMed 文献 · Arch Pathol Lab Med · 2025-01-01

该单中心研究回顾了1994至2022年592例腮腺活检(粗针活检356例,切开活检236例),将诊断转化为类MSRSGC分类器并与恶性风险等终点比较。粗针活检非诊断率高于切开活检(7.30% vs 2.12%,P < .001),组织体积影响粗针活检充分性,类MSRSGC风险分组表现出良好的恶性风险区分能力(敏感性85.5%,特异性100%)。

要点

  • 粗针活检非诊断率7.30%,高于切开活检的2.12%(P < .001)。
  • 粗针活检充分性的最小和最佳组织体积分别为4.76 mm³和12.92 mm³。
  • 类MSRSGC风险分层在粗针/切开活检中敏感性85.5%、特异性100%、准确性92.3%。

核心结论

  • 粗针活检和切开活检适用风险分层系统,但与细针穿刺活检存在差异,尤其因恶性基线患病率高。
  • 特定诊断常可行且与切除标本一致,粗针活检组织体积可指导充分采样推荐。

研究设计与样本

  • 单机构回顾性研究,检索1994-2022年592例腮腺活检记录(粗针活检356例,切开活检236例)及临床病理数据。
  • 将诊断转化为类MSRSGC分类器,与恶性风险等终点比较。

主要发现

  • 总恶性检出率为223/592(37.7%)。
  • 粗针活检非诊断率26/356(7.30%),切开活检5/236(2.12%),P < .001。
  • 粗针活检充分性的最小和最佳组织体积分别为4.76 mm³和12.92 mm³。
  • 类MSRSGC风险分组:敏感性85.5%,特异性100%,准确性92.3%,AUC 0.9677。

关键数值与推荐

  • 粗针活检非诊断率7.30%,切开活检2.12%(P < .001)。
  • 粗针活检充分性最小体积4.76 mm³,最佳体积12.92 mm³。
  • 类MSRSGC风险分层敏感性85.5%,特异性100%,准确性92.3%,AUC 0.9677。

临床怎么用

  • 腮腺粗针活检和切开活检可参考类MSRSGC风险分层进行恶性风险评估。
  • 粗针活检需关注组织体积,建议达到最小4.76 mm³和最佳12.92 mm³以确保充分性。

局限性

  • 单机构回顾性研究,时间跨度大,可能存在选择偏倚。
  • 仅部分患者有随访切除数据,一致性评估样本有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT.—: Unlike parotid fine-needle aspiration biopsy, standardized reporting for core needle biopsy (CNB) and incisional biopsy (IB) is not established. OBJECTIVE.—: To examine the value of risk stratification by a Milan System for Reporting Salivary Gland Cytopathology (MSRSGC)-like classifier for parotid CNB/IB. DESIGN.—: Five hundred ninety-two parotid biopsy records (CNB = 356, IB = 236) were retrieved (1994-2022) along with clinicopathologic data. Diagnoses were transformed to an MSRSGC-like classifier and compared with end points including risk of malignancy. RESULTS.—: Over time, CNB was progressively more used compared with IB. Overall malignancy call rate was 223 of 592 (37.7%). Common specific diagnoses included Warthin tumor, lymphoma subtypes, and metastatic squamous cell carcinoma for CNB and IB, in addition to pleomorphic adenoma for CNB. Descriptive diagnoses were still frequent. Nondiagnostic rates were higher in CNB (26 of 356; 7.30%) than IB (5 of 236; 2.12%; P < .001). Tissue volumes significantly influenced CNB adequacy, with minimum and optimal volumes of 4.76 mm³ (J index, receiver operating characteristic curve) and 12.92 mm³ (95th percentile of distribution), respectively. One hundred forty-four patients (112 CNBs) had follow-up resections; diagnoses were concordant for 66 of 73 adequate CNBs (90.41%). Our restructured risk grouping of MSRSGC categories performed robustly in terms of risk of malignancy (sensitivity = 85.5%, specificity = 100%, accuracy = 92.3%, area under the curve = 0.9677). CONCLUSIONS.—: Although CNB and IB are amenable to a risk stratification system, there are some differences as compared with fine-needle aspiration biopsy, particularly given the high baseline prevalence of malignancy. Specific diagnoses are often feasible and concordant with resection. CNB tissue volume can inform optimal and minimal sampling recommendations for adequacy.

来源:Arch Pathol Lab Med,查看原文。版权归原作者所有。

引用

  1. Rammal R, Wang Q, Ohori NP, et al. Performance Characteristics of Incisional and Core Needle Biopsies for Diagnosis in Parotid Gland: Single-Institutional Experience and Assessment of the Value of a Milan System for Reporting Salivary Gland Cytopathology-Like Risk Stratification Model. Arch Pathol Lab Med. 2025. PMID: 38952287. doi:10.5858/arpa.2024-0051-OA

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。